A detailed history of Northern Trust Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Northern Trust Corp holds 21,023,386 shares of ABT stock, worth $2.15 Billion. This represents 0.42% of its overall portfolio holdings.

Number of Shares
21,023,386
Previous 21,628,826 2.8%
Holding current value
$2.15 Billion
Previous $2.38 Billion 0.37%
% of portfolio
0.42%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $66.3 Million - $73.2 Million
-605,440 Reduced 2.8%
21,023,386 $2.39 Billion
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $125 Million - $153 Million
-1,387,409 Reduced 6.03%
21,628,826 $2.38 Billion
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $32.8 Million - $39.4 Million
343,559 Added 1.52%
23,016,235 $2.23 Billion
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $125 Million - $140 Million
-1,244,616 Reduced 5.2%
22,672,676 $2.47 Billion
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $8.85 Million - $10.4 Million
-91,352 Reduced 0.38%
23,917,292 $2.42 Billion
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $4.07 Million - $4.78 Million
-42,841 Reduced 0.18%
24,008,644 $2.64 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $24.4 Million - $28.2 Million
-252,008 Reduced 1.04%
24,051,485 $2.33 Billion
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $109 Million - $131 Million
-1,065,428 Reduced 4.2%
24,303,493 $2.64 Billion
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $17.6 Million - $21.5 Million
-154,658 Reduced 0.61%
25,368,921 $3 Billion
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $5.69 Million - $6.96 Million
-49,224 Reduced 0.19%
25,523,579 $3.59 Billion
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $60.5 Million - $66.9 Million
-518,509 Reduced 1.99%
25,572,803 $3.02 Billion
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $32.6 Million - $38.3 Million
-307,694 Reduced 1.17%
26,091,312 $3.02 Billion
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $2.76 Million - $3.25 Million
-25,379 Reduced 0.1%
26,399,006 $3.16 Billion
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $63.4 Million - $69.1 Million
-603,713 Reduced 2.23%
26,424,385 $2.89 Billion
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $587,778 - $713,814
-6,414 Reduced 0.02%
27,028,098 $2.94 Billion
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $18.7 Million - $23.9 Million
244,131 Added 0.91%
27,034,512 $2.47 Billion
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $3.15 Million - $4.61 Million
50,211 Added 0.19%
26,790,381 $2.11 Billion
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $36.8 Million - $41 Million
468,707 Added 1.78%
26,740,170 $2.32 Billion
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $17.8 Million - $19.3 Million
-217,482 Reduced 0.82%
26,271,463 $2.2 Billion
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $2.83 Million - $3.3 Million
-38,835 Reduced 0.15%
26,488,945 $2.23 Billion
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $5.04 Million - $6.09 Million
-76,124 Reduced 0.29%
26,527,780 $2.12 Billion
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $46.5 Million - $52.6 Million
708,691 Added 2.74%
26,603,904 $1.92 Billion
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $12.1 Million - $14.6 Million
-199,584 Reduced 0.76%
25,895,213 $1.9 Billion
Q2 2018

Sep 18, 2018

SELL
$57.57 - $63.54 $6.42 Million - $7.09 Million
-111,597 Reduced 0.43%
26,094,797 $1.59 Billion
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $8.41 Million - $9.29 Million
146,145 Added 0.56%
26,206,394 $1.6 Billion
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $42.1 Million - $47.6 Million
-748,371 Reduced 2.79%
26,060,249 $1.56 Billion
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $25.4 Million - $27.2 Million
-473,064 Reduced 1.73%
26,808,620 $1.53 Billion
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $1.31 Billion - $1.46 Billion
27,281,684
27,281,684 $1.46 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.